Evaluating Outcomes of Immediate Breast Reconstruction (POBRAD-M)

NAUnknownINTERVENTIONAL
Enrollment

209

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2020

Conditions
Breast NeoplasmsBreast Diseases
Interventions
PROCEDURE

Breast reconstruction - implant and an ADM (SurgiMend)

Skin or nipple sparing mastectomy and immediate breast reconstruction with implants and SurgiMend

PROCEDURE

Breast reconstruction- autologous tissue

Skin or nipple sparing mastectomy and immediate breast reconstruction with autologous tissue

PROCEDURE

Breast reconstruction- implant + dermal sling/LD flap

Skin or nipple sparing mastectomy and immediate breast reconstruction using an implant and a dermal sling or a latissimus dorsi flap

Trial Locations (6)

Unknown

Royal Hampshire County Hospital, Winchester

Frimley Park Hospitals NHS Foundation Trust, Frimley

Leeds Teaching Hospitals, Leeds

Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield

Royal Cornwall Hospital, Truro

SE1 9RT

Department of Research Oncology, King's College London, London

Sponsors
All Listed Sponsors
collaborator

Guy's and St Thomas' NHS Foundation Trust

OTHER

collaborator

Integra LifeSciences Corporation

INDUSTRY

lead

King's College London

OTHER

NCT02557906 - Evaluating Outcomes of Immediate Breast Reconstruction (POBRAD-M) | Biotech Hunter | Biotech Hunter